Arcellx, Inc.ACLXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR-88.5%
5Y CAGR-64.6%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-88.5%/yr
Annual compound
5Y CAGR
-64.6%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20250.33%
202417.37%
2023-10.50%
2022219.00%
202187.11%
202058.92%
2019157.95%
20180.00%